FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/01/061667 [Registered on: 19/01/2024] Trial Registered Prospectively
Last Modified On: 09/01/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Single Arm Study 
Public Title of Study   Study of Effect of Laser Treatment in Patients with High Pressure in the Eye Using a Scan Machine 
Scientific Title of Study   Relationship Between Iris Thickness and Angle Opening After Laser Peripheral Iridotomy in Primary Angle Closure Disease: An AS OCT Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Meghana Mulpuri 
Designation  Primary DNB Resident (Ophthalmology) 
Affiliation  Sankara Eye Hospital 
Address  Room 26, Glaucoma Department, Sankara Eye Hospital, Thirthahalli Road, Harakere, Shimoga, Karnataka India

Shimoga
KARNATAKA
577202
India 
Phone  9494634422  
Fax    
Email  mulpuri.meghana@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kamala S 
Designation  Senior Consultant Glaucoma 
Affiliation  Sankara Eye Hospital 
Address  Room 26, Glaucoma Department, Sankara Eye Hospital, Thirthahalli Road, Harakere, Shimoga, Karnataka India

Shimoga
KARNATAKA
577202
India 
Phone  9480362192  
Fax    
Email  kamala13@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Meghana Mulpuri 
Designation  Primary DNB Resident (Ophthalmology) 
Affiliation  Sankara Eye Hospital 
Address  Room 26, Glaucoma Department, Sankara Eye Hospital, Thirthahalli Road, Harakere, Shimoga, Karnataka India

Shimoga
KARNATAKA
577202
India 
Phone  9494634422  
Fax    
Email  mulpuri.meghana@gmail.com  
 
Source of Monetary or Material Support  
Sankara Eye Hospital, Thirthahalli Road, Harakere, Shimoga, Karnataka India 577202 
 
Primary Sponsor  
Name  Sankara Eye Hospital 
Address  Sankara Eye Hospital, Thirthahalli Road, Harakere, Shimoga, Karnataka India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Meghana Mulpuri  Sankara Eye Hospital  Room 26, Glaucoma Department, Sankara Eye Hospital, Thirthahalli Road, Harakere, Shimoga, Karnataka India 577202
Shimoga
KARNATAKA 
9494634422

mulpuri.meghana@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Review Board of Sankara Eye Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H402||Primary angle-closure glaucoma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Confirmed diagnosis of Primary Angle Closure Disease based on clinical evaluation and diagnostic tests.
2. Willing and able to provide informed consent for AS OCT imaging.
3. Ability to cooperate with imaging procedure AS OCT. 
 
ExclusionCriteria 
Details  1. Patients with secondary cause of angle closure.
2. Patients requiring peripheral iridotomy augmentation.
3. Patients with plateau iris syndrome.
4. History of previous angle surgery or laser treatment.
5. Presence of corneal abnormalities that may interfere with the AS OCT imaging.
6. Eyes with incomplete laser peripheral iridotomy perforation.
7. Use of topical or systemic medications that could affect the anterior chamber.
8. History of ocular trauma or surgery within the past 6 months.
9. Pregnancy or breastfeeding in female participants. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. To correlate variations in iris thickness with variations in angle opening post iridotomy.
2. To assess the impact of baseline iris morphology on post iridotomy outcomes. 
1. By comparing the iris thickness at various distances to angle opening distance and trabecular iris angle at pre-treatment, post one week and post 6 months of treatment.
2. To compare the pre-treatment iris thickness at various distance to the angle opening distance and trabecular iris angle at one week and six months post treatment. 
 
Secondary Outcome  
Outcome  TimePoints 
To analyse the effect of angle opening after iridotomy at the end of 6 months  6 months 
 
Target Sample Size   Total Sample Size="114"
Sample Size from India="114" 
Final Enrollment numbers achieved (Total)= "59"
Final Enrollment numbers achieved (India)="59" 
Phase of Trial   N/A 
Date of First Enrollment (India)   29/01/2024 
Date of Study Completion (India) 01/08/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is an observational, single arm, follow up study investigating the relationship between iris thickness and angle opening following laser peripheral iridotomy in patients diagnosed with primary angle closure disease using Anterior Segment Optical Coherence Tomography. The primary objectives are to correlate the variations in iris thickness with variations in angle opening post iridotomy, and to assess the impact of baseline iris morphology on post iridotomy outcomes. These will be assessed at follow ups of one week and six months after the advised procedure of laser iridotomy. The secondary objective is to analyse the effect and amount of angle opening after iridotomy at the end of six months. 
Close